Results 151 to 160 of about 41,395 (219)

Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential. [PDF]

J Biol Chem
Golonka RM, Intravaia LE, Shaqra AM, Li Q, Chen Y, Humphries F, Kurt-Yilmaz N, Fitzgerald KA, Schiffer CA, Wang Y, Cavacini LA.   +10 more
europepmc   +1 more source

Affinity- and Format-Dependent Pharmacokinetics of ⁸⁹Zr-Labeled Albumin-Binding VHH Constructs. [PDF]

Pharmaceuticals (Basel)
Leekens S, Casteels P, Van Bogaert T, Deschaght P, De Brabandere V, Cawthorne C, Bormans G, Cleeren F.   +7 more
europepmc   +1 more source

Systematic perturbation of cultures of K. phaffii by carbon co-feeding show gene signatures associated with production of recombinant proteins. [PDF]

Microb Cell Fact
Acharya R, Hinckley J, Barry R, Cha E, Narayanan H, Sunday BC, Ford H, Whittaker CA, Love JC.   +8 more
europepmc   +1 more source

A High-Affinity Nanobody Selectively Recognizing KPC-2/KPC-3: Biochemical and Structural Insights. [PDF]

Biomolecules
Hamdi E, Khamessi O, Piccirilli A, Dhaouadi S, Zarrouk S, Brisdelli F, Dabbek H, Saihi MH, Bouhaouala-Zahar B, Ben Abderrazek R, Perilli M.   +10 more
europepmc   +1 more source

N-glycosylated VHH Antibodies

Trends in Glycoscience and Glycotechnology, 2023
openaire   +1 more source

Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers. [PDF]

Res Pract Thromb Haemost
Alessi MC, Moulard M, Boulay-Moine D, Pons C, Margier M, Vessière C, Poggi M, Pigaglio T, Dignat-George F, Roussel A, Burtey S, Bonello L, Chames P, Bonjean R, Peiretti F.   +14 more
europepmc   +1 more source

Multidimensional maturation of antibody variable domains with machine-learning assistance. [PDF]

MAbs
Ito T, Kawada S, Nakazawa H, Murakami A, Umetsu M.   +4 more
europepmc   +1 more source

Poxvirus dsDNA genomes differentially activate AIM2 or NLRP3 inflammasomes in human primary cells. [PDF]

EMBO J
Tesfamariam YM, Christensen MH, Diehl S, Klein T, Lingnau JM, Normann S, Hagelauer E, Herbert M, Reimer S, Joshi RP, Engels P, Pritzl S, Fontana P, Zillinger T, Hartmann G, Eis-Hübinger A, Lam MC, Walgenbach KJ, Meissner F, Wu H, Schmidt FI.   +20 more
europepmc   +1 more source

More tools to uncover cancer cells. [PDF]

Mol Ther Oncol
Pignataro MF, Santos J.
europepmc   +1 more source

Glycan-based biological degraders targeting the cytokine immune axis. [PDF]

Commun Biol
Seifert M, Kollenkirchen T, Ernst A, Rasoulinejad S, Koellner SMS, Schneider AK, Luzarowski M, Lübbehusen N, Wu D, Kannt A, Safarian S.   +10 more
europepmc   +1 more source